Novus Biologicals and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes

San Jose, CA, July 30, 2008 --(PR.com)-- AnaSpec and Novus Biologicals today announced a licensing agreement that will allow Novus Biologicals to label Novus antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes.

HiLytePlus™ and HiLyte Fluor™ are AnaSpec's proprietary series of high performance fluorescent dyes optimized for long wavelength biomarker labeling.

"Novus Biologicals has established a strong reputation in the scientific community as a provider of high-quality antibodies," noted Dr. Anita Hong, AnaSpec's president. "We are pleased to partner with Novus in offering the performance advantages of our HiLyte™ dyes to a broader spectrum of researchers."

"After thorough evaluation, we are pleased to incorporate the HiLytePlus™ and HiLyte Fluor™ series of fluorescent dyes into the Novus line of antibodies," stated Karen Padgett, Novus Biologicals' president. "The addition of high performance dye labels to our antibody collection will provide a significant enhancement to the research tools available to our customers."

About AnaSpec
AnaSpec, Inc. is a leading provider of integrated proteomics solutions™ for worldwide life science research. With a vision for innovation through synergy, AnaSpec offers expertise in three primary technologies: peptides, detection reagents, and combinatorial chemistry.

About Novus Biologicals
The mission of Novus Biologicals, Inc. is to accelerate scientific discovery by developing and marketing unique products in the forefront of science. Novus Biologicals is committed to supporting the scientific community with a 100% product guarantee on our 60,000 product offerings.

###